Literature DB >> 12710502

Cellular immunity and Chlamydia genital infection: induction, recruitment, and effector mechanisms.

Kathleen A Kelly1.   

Abstract

Chlamydia trachomatis is one of the major causes of bacterial sexually transmitted disease worldwide. The initial infection of endocervical epithelium in females is asymptomatic and commonly ascends to fallopian tubes when left untreated. Immunity to Chlamydia develops after infection and appears to provide short-term protection. Consequently, a significant rate of reinfection occurs among sexually active individuals, which can result in reproductive disability. T helper type 1 responses are implicated in providing protective immunity but may also contribute to tubal infertility. The purpose of this chapter is to review the factors that regulate the induction and recruitment of protective cellular immune responses within the local genital mucosa. An understanding of these events is important for the design of a protective vaccine and control of immunopathologic reactions.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12710502     DOI: 10.1080/08830180305229

Source DB:  PubMed          Journal:  Int Rev Immunol        ISSN: 0883-0185            Impact factor:   5.311


  22 in total

1.  Intranasal vaccination with a secreted chlamydial protein enhances resolution of genital Chlamydia muridarum infection, protects against oviduct pathology, and is highly dependent upon endogenous gamma interferon production.

Authors:  Ashlesh K Murthy; James P Chambers; Patricia A Meier; Guangming Zhong; Bernard P Arulanandam
Journal:  Infect Immun       Date:  2006-11-21       Impact factor: 3.441

2.  The protective efficacy of chlamydial protease-like activity factor vaccination is dependent upon CD4+ T cells.

Authors:  Cathi Murphey; Ashlesh K Murthy; Patricia A Meier; M Neal Guentzel; Guangming Zhong; Bernard P Arulanandam
Journal:  Cell Immunol       Date:  2006-11-20       Impact factor: 4.868

3.  Chlamydial protease-like activity factor induces protective immunity against genital chlamydial infection in transgenic mice that express the human HLA-DR4 allele.

Authors:  Ashlesh K Murthy; Yu Cong; Cathi Murphey; M Neal Guentzel; Thomas G Forsthuber; Guangming Zhong; Bernard P Arulanandam
Journal:  Infect Immun       Date:  2006-10-02       Impact factor: 3.441

4.  Distinct defensin profiles in Neisseria gonorrhoeae and Chlamydia trachomatis urethritis reveal novel epithelial cell-neutrophil interactions.

Authors:  Edith Porter; Huixia Yang; Sujata Yavagal; Gloria C Preza; Omar Murillo; Heriberto Lima; Sheila Greene; Laily Mahoozi; Marcia Klein-Patel; Gill Diamond; Sunita Gulati; Tomas Ganz; Peter A Rice; Alison J Quayle
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

5.  Enhanced fusion and virion incorporation for HIV-1 subtype C envelope glycoproteins with compact V1/V2 domains.

Authors:  Marielle Cavrois; Jason Neidleman; Mario L Santiago; Cynthia A Derdeyn; Eric Hunter; Warner C Greene
Journal:  J Virol       Date:  2013-12-11       Impact factor: 5.103

6.  CXCL13 expression in Chlamydia trachomatis infection of the female reproductive tract.

Authors:  M King; H Poya; J Rao; S Natarajan; A W Butch; N Aziz; S Kok; M H Chang; J M Lyons; K Ault; K A Kelly
Journal:  Drugs Today (Barc)       Date:  2009-11       Impact factor: 2.245

7.  Cytokine expression pattern in the genital tract of Chlamydia trachomatis positive infertile women - implication for T-cell responses.

Authors:  B S Reddy; S Rastogi; B Das; S Salhan; S Verma; A Mittal
Journal:  Clin Exp Immunol       Date:  2004-09       Impact factor: 4.330

8.  Heat denatured enzymatically inactive recombinant chlamydial protease-like activity factor induces robust protective immunity against genital chlamydial challenge.

Authors:  Bharat K R Chaganty; Ashlesh K Murthy; Shankar J Evani; Weidang Li; M Neal Guentzel; James P Chambers; Guangming Zhong; Bernard P Arulanandam
Journal:  Vaccine       Date:  2010-01-05       Impact factor: 3.641

9.  A Vibrio cholerae ghost-based subunit vaccine induces cross-protective chlamydial immunity that is enhanced by CTA2B, the nontoxic derivative of cholera toxin.

Authors:  Eno E Ekong; Daniel N Okenu; Jayanti Mania-Pramanik; Qing He; Joseph U Igietseme; Godwin A Ananaba; Deborah Lyn; Carolyn Black; Francis O Eko
Journal:  FEMS Immunol Med Microbiol       Date:  2008-11-18

10.  Modulation of cytokines and transcription factors (T-Bet and GATA3) in CD4 enriched cervical cells of Chlamydia trachomatis infected fertile and infertile women upon stimulation with chlamydial inclusion membrane proteins B and C.

Authors:  Rishein Gupta; Harsh Vardhan; Pragya Srivastava; Sudha Salhan; Aruna Mittal
Journal:  Reprod Biol Endocrinol       Date:  2009-08-22       Impact factor: 5.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.